Join Us at the Oligonucleotide Therapeutics Society (OTS) 2024 Annual Meeting
We are excited to invite you to join us at the Oligonucleotide Therapeutics Society (OTS) 2024 Annual Meeting, the leading event for professionals in oligonucleotide research and therapeutics. Shauli Talmor, Customer Success Manager at SciLeads will be attending the event in Montreal, Canada, from October 6th to 9th, 2024. This is an excellent opportunity to connect with researchers, scientists, and industry leaders who are pioneering advancements in oligonucleotide therapeutics.
About OTS 2024
The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a globally recognized event that gathers experts in the field of oligonucleotide research. This event focuses on the latest advancements in therapeutic applications, including antisense, RNAi, aptamers, and more. OTS 2024 will feature a comprehensive program including keynote presentations, scientific sessions, and networking opportunities. This meeting is a must-attend for anyone involved in the development and application of oligonucleotide-based therapies.
Event Location
Location: Montreal, Quebec, Canada
Date: October 6th – 9th, 2024
Agenda: Link to Conference Program
Key Speakers and Information
Join us to hear from some of the most influential voices in oligonucleotide therapeutics. OTS 2024 will feature keynote speakers such as:
- Dr. Brenda Bass, Distinguished Professor, University of Utah, USA
- Dr. Frank Bennett, Chief Scientific Officer, Ionis Pharmaceuticals, USA
- Dr. Anastasia Khvorova, Professor of Neurology, University of Massachusetts Medical School, USA
- Dr. Arthur Levin, Executive Vice President, Research and Development, Avidity Biosciences, USA
For more details on speakers and the full agenda, please refer to the conference program.
Meet the Team
Meet our team member who will be representing us at OTS 2024:
- Shauli Talmor, Senior Scientist
Connect with Shauli on LinkedIn